<DOC>
	<DOCNO>NCT01059864</DOCNO>
	<brief_summary>All patient instruct eat therapeutic lifestyle diet receive CP-690,550 throughout 12 week study . After 6 week , half receive cholesterol lower agent , atorvastatin , half matching placebo . This study first measure effect CP-690,550 cholesterol level effect add atorvastatin level .</brief_summary>
	<brief_title>Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>must diagnose active rheumatoid arthritis agree participate study sign inform consent document History serious infection within past 6 month test positive TB uncontrolled clinically significant disease laboratory test require administration prohibit medication study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>cholesterol</keyword>
	<keyword>lipid</keyword>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>CP-690</keyword>
	<keyword>550</keyword>
</DOC>